At SupplySide West, dietary supplement industry professionals answered polling questions about the Food and Drug Administration, legislative priorities, counterfeit products and more.
Four former FDA officials, including several who worked on dietary supplement issues, discuss the myriad impacts of a government shutdown on the Food and Drug Administration.
The debacle facing NMN supplement brands reflects growing concerns over a drug "exclusion" provision in U.S. law that FDA concluded is applicable to β-NMN.
FDA intends to finalize parts of a 2016 draft guidance on new dietary ingredients (NDI) before publishing an NDI document related to "enforcement discretion."